Hepatitis E virus

Medecine et Maladies Infectieuses

Volumn 43, Issue 7, 2013, Pages 263-270

  Abravanel, F ^a,b   Lhomme, S ^a,b   Dubois, M ^a,b   Peron, J M ^b   Alric, L ^b   Kamar, N ^a,c   Izopet, J ^a,b  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Chronic infection; Hepatitis E virus

Indexed keywords

DRINKING WATER; HEPATITIS E VACCINE; HEV 239; PEGINTERFERON; PLACEBO; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA;

ACUTE HEPATITIS; ALGORITHM; ASYMPTOMATIC INFECTION; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL FEATURE; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOASSAY; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LABORATORY TEST; MOLECULAR BIOLOGY; MONOTHERAPY; NEUROLOGIC DISEASE; NONHUMAN; PANCREATITIS; PREGNANT WOMAN; PUBLIC HEALTH SERVICE; RELAPSE; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE; SPLENOMEGALY; THROMBOCYTOPENIA; VERTICAL TRANSMISSION; VIRAL CLEARANCE; VIRAL CONTAMINATION; VIREMIA; VIRUS DETECTION; VIRUS SHEDDING; VIRUS TRANSMISSION; WATER CONTAMINATION; ZOONOSIS;

CHRONIC INFECTION; HEPATITIS E VIRUS; INFECTION CHRONIQUE; VIRUS DE L'HÉPATITE E;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BLOOD TRANSFUSION; DEVELOPING COUNTRIES; FECES; FEMALE; GENOME, VIRAL; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, VIRAL, ANIMAL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN M; LIVER TRANSPLANTATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; SWINE; SWINE DISEASES; VIRAL HEPATITIS VACCINES; WATER MICROBIOLOGY; WATER POLLUTION; ZOONOSES;

EID: 84882651826     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2013.03.005     Document Type: Review

References (79)

1. Ahmad I., Holla R.P., Jameel S. Molecular virology of hepatitis E virus. Virus Res 2011, 161:47-58.
2. Lu L., Li C., Hagedorn C.H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006, 16:5-36.
3. Colson P., Romanet P., Moal V., Borentain P., Purgus R., Benezech A., et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 2012, 18:1361-1364.
4. Hakze-van der Honing R.W., van Coillie E., Antonis A.F., van der Poel W.H. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PloS One 2011, 6:e22673.
5. Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998, 72:9714-9721.
6. Haqshenas G., Shivaprasad H.L., Woolcock P.R., Read D.H., Meng X.J. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J Gen Virol 2001, 82:2449-2462.
7. Johne R., Plenge-Bonig A., Hess M., Ulrich R.G., Reetz J., Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol 2010, 91:750-758.
8. Ma H., Zheng L., Liu Y., Zhao C., Harrison T.J., Ma Y., et al. Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PloS One 2010, 5:e9160.
9. Raj V.S., Smits S.L., Pas S.D., Provacia L.B., Moorman-Roest H., Osterhaus A.D., et al. Novel hepatitis e virus in ferrets, the Netherlands. Emerg Infect Dis 2012, 18:1369-1370.
10. Cossaboom C.M., Cordoba L., Sanford B.J., Pineyro P., Kenney S.P., Dryman B.A., et al. Cross-species infection of swine with a novel rabbit, but not rat, strain of hepatitis E virus isolated in the United States. J Gen Virol 2012, 93:1687-1695.
11. Izopet J., Dubois M., Bertagnoli S., Lhomme S., Marchandeau S., Boucher S., et al. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg Infect Dis 2012, 18:1274-1281.
12. Batts W., Yun S., Hedrick R., Winton J. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res 2011, 158:116-123.
13. Takahashi M., Nishizawa T., Sato H., Sato Y., Jirintai, Nagashima S., et al. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol 2011, 92:902-908.
14. Krawczynski K., Meng X.J., Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res 2011, 161:78-83.
15. Okamoto H. Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood. Rev Med Virol 2011, 21:18-31.
16. Takahashi M., Tanaka T., Takahashi H., Hoshino Y., Nagashima S., Jirintai, et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 2010, 48:1112-1125.
17. Purcell R.H., Emerson S.U. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008, 48:494-503.
18. Teshale E.H., Grytdal S.P., Howard C., Barry V., Kamili S., Drobeniuc J., et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010, 50:1006-1010.
19. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255.
20. Rein D.B., Stevens G.A., Theaker J., Wittenborn J.S., Wiersma S.T. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012, 55:988-997.
21. Dalton H.R., Thurairajah P.H., Fellows H.J., Hussaini H.S., Mitchell J., Bendall R., et al. Autochthonous hepatitis E in southwest England. J Viral Hepat 2007, 14:304-309.
22. Mansuy J.M., Peron J.M., Abravanel F., Poirson H., Dubois M., Miedouge M., et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004, 74:419-424.
23. Renou C., Cadranel J.F., Bourliere M., Halfon P., Ouzan D., Rifflet H., et al. Possible zoonotic transmission of hepatitis E from pet swine to its owner. Emerg Infect Dis 2007, 13:1094-1096.
24. Mansuy J.M., Abravanel F., Miedouge M., Mengelle C., Merviel C., Dubois M., et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009, 44:74-77.
25. Legrand-Abravanel F., Mansuy J.M., Dubois M., Kamar N., Peron J.M., Rostaing L., et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009, 15:110-114.
26. Bouquet J., Tesse S., Lunazzi A., Eloit M., Rose N., Nicand E., et al. Close similarity between sequences of hepatitis E virus recovered from humans and swine, France, 2008-2009. Emerg Infect Dis 2011, 17:2018-2025.
27. Christensen P.B., Engle R.E., Hjort C., Homburg K.M., Vach W., Georgsen J., et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008, 47:1026-1031.
28. Engle R.E., Yu C., Emerson S.U., Meng X.J., Purcell R.H. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002, 40:4576-4580.
29. Li T.C., Chijiwa K., Sera N., Ishibashi T., Etoh Y., Shinohara Y., et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005, 11:1958-1960.
30. Tei S., Kitajima N., Takahashi K., Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003, 362:371-373.
31. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202:835-844.
32. Crossan C., Baker P.J., Craft J., Takeuchi Y., Dalton H.R., Scobie L. Hepatitis E virus genotype 3 in shellfish, United Kingdom. Emerg Infect Dis 2012, 18:2085-2087.
33. Emerson S.U., Arankalle V.A., Purcell R.H. Thermal stability of hepatitis E virus. J Infect Dis 2005, 192:930-933.
34. Khuroo M.S., Kamili S., Yattoo G.N. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004, 19:778-784.
35. Colson P., Coze C., Gallian P., Henry M., De Micco P., Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007, 13:648-649.
36. Boxall E., Herborn A., Kochethu G., Pratt G., Adams D., Ijaz S., et al. Transfusion-transmitted hepatitis E in a "nonhyperendemic" country. Transfus Med 2006, 16:79-83.
37. Matsubayashi K., Kang J.H., Sakata H., Takahashi K., Shindo M., Kato M., et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008, 48:1368-1375.
38. Baylis S.A., Gartner T., Nick S., Ovemyr J., Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012, 103:89-90.
39. Baylis S.A., Koc O., Nick S., Blumel J. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2012, 102:182-183.
40. Dalton H.R., Fellows H.J., Stableforth W., Joseph M., Thurairajah P.H., Warshow U., et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007, 26:1429-1435.
41. Davern T.J., Chalasani N., Fontana R.J., Hayashi P.H., Protiva P., Kleiner D.E., et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011, 141:1665-1672. [e1661-e1669].
42. Dalton H.R., Stableforth W., Thurairajah P., Hazeldine S., Remnarace R., Usama W., et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008, 20:784-790.
43. Peron J.M., Mansuy J.M., Poirson H., Bureau C., Dupuis E., Alric L., et al. Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. Gastroenterol Clin Biol 2006, 30:757-762.
44. Said B., Ijaz S., Kafatos G., Booth L., Thomas H.L., Walsh A., et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009, 15:1738-1744.
45. Patra S., Kumar A., Trivedi S.S., Puri M., Sarin S.K. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007, 147:28-33.
46. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
47. Gerolami R., Moal V., Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008, 358:859-860.
48. Haagsma E.B., van den Berg A.P., Porte R.J., Benne C.A., Vennema H., Reimerink J.H., et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008, 14:547-553.
49. Ollier L., Tieulie N., Sanderson F., Heudier P., Giordanengo V., Fuzibet J.G., et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009, 150:430-431.
50. Peron J.M., Mansuy J.M., Recher C., Bureau C., Poirson H., Alric L., et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006, 21:1223-1224.
51. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361:1025-1027.
52. Kenfak-Foguena A., Schoni-Affolter F., Burgisser P., Witteck A., Darling K.E., Kovari H., et al. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011, 17:1074-1078.
53. Kamar N., Mansuy J.M., Cointault O., Selves J., Abravanel F., Danjoux M., et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008, 8:1744-1748.
54. Halac U., Beland K., Lapierre P., Patey N., Ward P., Brassard J., et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012, 160:871-874. [e871].
55. le Coutre P., Meisel H., Hofmann J., Rocken C., Vuong G.L., Neuburger S., et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58:699-702.
56. Abravanel F., Mansuy J.M., Huynh A., Kamar N., Alric L., Peron J.M., et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012, 54:152-155.
57. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Lhomme S., Mansuy J.M., Muscari F., et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011, 17:30-37.
58. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
59. Naik A., Gupta N., Goel D., Ippagunta S.K., Sharma K., Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 2013, 20(4):e138-e140.
60. Kamar N., Bendall R.P., Peron J.M., Cintas P., Prudhomme L., Mansuy J.M., et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011, 17:173-179.
61. Cheung M.C., Maguire J., Carey I., Wendon J., Agarwal K. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol 2012, 11:618-622.
62. Kamar N., Izopet J., Cintas P., Garrouste C., Uro-Coste E., Cointault O., et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010, 10:1321-1324.
63. Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011, 161:15-22.
64. Kamar N., Weclawiak H., Guilbeau-Frugier C., Legrand-Abravanel F., Cointault O., Ribes D., et al. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 2012, 93:617-623.
65. Huang S., Zhang X., Jiang H., Yan Q., Ai X., Wang Y., et al. Profile of acute infectious markers in sporadic hepatitis E. PloS One 2010, 5:e13560.
66. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
67. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009, 16:772-774.
68. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010, 82:799-805.
69. Mansuy J.M., Bendall R., Legrand-Abravanel F., Saune K., Miedouge M., Ellis V., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011, 17:2309-2312.
70. Wenzel J.J., Preiss J., Schemmerer M., Huber B., Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2012, 207:497-500.
71. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010, 50:e30-e33.
72. Kamar N., Rostaing L., Abravanel F., Garrouste C., Lhomme S., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 2010, 139:1612-1618.
73. Mallet V., Nicand E., Sultanik P., Chakvetadze C., Tesse S., Thervet E., et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010, 153:85-89.
74. Chaillon A., Sirinelli A., De Muret A., Nicand E., d'Alteroche L., Goudeau A. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011, 30:841-843.
75. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52:60-62.
76. Peron J.M., Dalton H., Izopet J., Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?. J Hepatol 2011, 54:1323-1324. [Author reply 1324-1325].
77. Goyal R., Kumar A., Panda S.K., Paul S.B., Acharya S.K. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 2012, 17:1091-1096.
78. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903.
79. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010, 376:895-902.